Alkylation specificity for a series of distamycin analogues that tether chlorambucil

Anti-Cancer Drug Design

Volumn 12, Issue 1, 1997, Pages 49-60

  Wyatt, Michael D ^a   Lee, Moses ^b   Hartley, John A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b FURMAN UNIVERSITY   (United States)

Author keywords

Alkylating agents; DNA; Minor groove binders

Indexed keywords

ALKYLATING AGENT; CHLORAMBUCIL; CHLORMETHINE DERIVATIVE; DISTAMYCIN A DERIVATIVE; GUANINE; IMIDAZOLE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DNA ALKYLATION; DNA SEQUENCE; DRUG CONJUGATION; DRUG DNA BINDING; DRUG SPECIFICITY; PRIORITY JOURNAL;

ALKYLATION; ANTINEOPLASTIC AGENTS, ALKYLATING; CHLORAMBUCIL; DISTAMYCINS;

EID: 0031029254     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ARCAMONE, F.M , ANIMATI, F., BARBIERI, B., CONFIGLIACCHI, E., D'ALESSIO, R., GERONI, C , GIULIANI, F.C., LAZZARI, E , MENOZZI, M. & MONGELLI, N (1989). Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives. Journal of Medicinal Chemistry, 32, 774.
2. BROGGINI, M., COLEY, H., MONGELLI, N., GRANDI, M , WYATT, M.D., HARTLEY, JA. & D'INCALCI, M. (1995). DNA sequence specific adenine alkylation by the novel antitumor drug tallimustine (FCE24517), a benzoyl nitrogen mustard derivative of distamycin. Nucleic Acids Research, 23, 81.
3. BROGGINI, M., ERBA, E., PONTI, M., BALLINARI, D., GERONI, C., SPREAFICO, F. & D'INCALCI, M. (1991). Selective DNA interaction of the novel distamycin derivative FCE 24517. Cancer Research, 51, 199.
4. CHEN, F.X., ZHANG, Y., CHURCH, K.M , BODELL. W.J & GOLD, B. (1993). DNA crosslinking, sister chromatid exchange and cytotoxicity of N-2-chloroethylnitrosoureas tethered to minor groove binding peptides. Carcinogenesis, 14, 935.
5. GEIERSTANGER, B.H & WEMMER, D.E. (1995). Complexes of the minor groove of DNA. Annual Review of Biophysics and Biomolecular Structures, 24, 463.
6. GILBERT, D.E., & FEIGON, J. (1991). Structural analysis of drug-DNA interactions. Current Opinions in Structural Biology, 1, 439.
7. GOURDIE, T.A., VALU, K K., GRAVATT, G.L., BORITZKI, T.J., BAGULEY B.C., WAKELIN, L P., WILSON, W.R , WOODGATE, P.D. & DENNY, W.A. (1990). DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the reactivity of the mustard. Journal of Medicinal Chemistry, 33, 1177.
8. HARTLEY, J.A (1993). Selectivity in alkylating agent-DNA interactions. In Molecular Aspects of Anticancer Drug-DNA Interactions. Waring, M. and Neidle, S. (eds), pp. 1-31. Macmillan: Basingstoke, .
9. KISSINGER, K , KROWICKI, K., DABROWIAK, J C. & LOWN. J.W. (1987). Molecular recognition between oligopeptides and nucleic acids. Monocationic imidazole lexitropsins that display enhanced GC sequence dependent DNA binding. Biochemistry, 26, 5590.
10. KOPKA, M.L., YOON, C., GOODSELL, D., PJURA, P. & DICKERSON, R.E. (1985). The molecular origin of DNA-drug specificity in netropsin. Proceedings of the National Academy of Science of the USA, 82, 1376.
11. 1H-NMR studies. Nucleic Acids Research, 16, 665.
12. LEE, M., RHODES, A.L., WYATT, M.D., D'INCALCI, M , FORROW, S. & HARTLEY, J.A. (1993a). In vitro Cytotoxicity of GC sequence directed alkylating agents related to distamycin. Journal of Medicinal Chemistry, 36, 863.
13. LEE, M., RHODES, A.L., WYATT, M.D , FORROW, S. & HARTLEY, J.A. (1993b). Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents. Anti-cancer Drug Design, 8, 173.
14. LEE, M , RHODES, A.L., WYATT, M.D , FORROW, S. & HARTLEY, J A. (1993c). GC base sequence recognition by oligo(imidazolecarboxamide) and C-terminus-modified analogues of distamycin deduced from circular dichroism, proton nuclear magnetic resonance, and methidiumpropyl-ethylenediamine-tetraacetate-iron(II) footprinting studies. Biochemistry, 32, 4237.
15. MANIATIS, T., FRITSCH, E.F. & SAMBROOK, J. (1982). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
16. MATTES, W.B., HARTLEY, J A & KOHN, K W. (1986a). DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards. Nucleic Acids Research, 14, 2971.
17. MATTES, W.B , HARTLEY, J.A. & KOHN, K.W. (1986b). Mechanism of DNA strand breakage by piperidine at sites of N7-alkylguanines. Biochimica Biophysica Acta, 868, 71.
18. PIEPER, R.O. & ERICKSON, L.C. (1990). DNA adenine adducts induced by nitrogen mustards and their role in transcription termination in vitro. Carcinogenesis, 11, 1739.
19. PONTI, M , FORROW, S.M , SOUHAMI, R.L., D'INCALCI, M. & HARTLEY, J.A. (1991). Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucleic Acids Research, 19, 2929.
20. REYNOLDS, V.L., MOLINEUX, I J., KAPLAN, D.J., SWENSON, D H. & HURLEY, L.H. (1985). Reaction of the antiftimor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity. Biochemistry, 24, 6228.
21. SIGURDSSON, S.T. & HOPKINS, P.B. (1994). Synthesis and reactions with DNA of a family of DNA-DNA affinity cross-linking agents. Tetrahedron, 50, 12065.
22. SIGURDSSON, S.T., RINK, S.M. & HOPKINS, P.B. (1993). Affinity cross-linking of duplex DNA by a pyrrole-oligopeptide conjugate. Journal of the American Chemical Society, 115, 12633.
23. SUNTERS, A., SPRINGER, C.J., BAGSHAWE, K D., SOUHAMI, R.L. & HARTLEY, J.A. (1992). The Cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mus[ards melphalan, chiorambucil and 4-[bis(2-chloroethyl)amino} benzoic acid. Biochemical Pharmacology, 44, 59.
24. WANG, P., BAUER, C.B., BENNETT, R.A. & POVIRK, L.F. (1991). Thermolabile adenine adducts and A.T base pair substitutions induced by nitrogen mustard analogues in an SV40-based shuttle plasmid. Biochemistry, 30, 11515.
25. WYATT, M.D , GARBIRAS, B.J., HASKELL, M.K., LEE, M., SOUHAMI, R L. & HARTLEY, J.A. (1994). Structure activity relationship of a series of nitrogen mustard and pyrrole containing minor groove binding agents related to distamycin. Anti-cancer Drug Des., 9, 511.
26. WYATT, M.D., LEE, M., GARBIRAS, B.J., SOUHAMI, R L. & HARTLEY, J.A. (1995). Sequence Specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity. Biochemistry, 34, 13034.
27. XIE, G., GUPTA, R. & LOWN, J.W. (1995). Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues. Anti-cancer Drug Des., 10, 389.
28. ZHANG, Y., CHEN F.X., MEHTA, P & GOLD, B. (1993). Groove- and sequence-selective alkylation of DNA by sulfonate esters tethered to lexitropsins. Biochemistry, 32, 7954.
29. ZIMMER, C., & WAHNERT, U. (1986). Non-intercalating DNA-binding ligands: Specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. Progress in Biophysical and Molecular Biology, 47, 31.